Lanfear Dennis M — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Lanfear Dennis M has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

Dennis M. Lanfear is the President and Chief Executive Officer of Coherus Oncology Inc, as disclosed in the SEC filing with CIK 0001420822 dated 2026-01-23. Coherus Oncology Inc is described as an oncology-focused company with LOQTORZI, a next-generation PD-1 inhibitor, and a pipeline targeting liver, lung, head & neck, and other cancers. In his role, Lanfear leads the company’s strategic direction and operational execution as it advances its oncology programs.

Board memberships

• Coherus Oncology Inc
• Coherus BioSciences, Inc.

Awards & honors

• Leading Coherus Oncology Inc's strategy and operations as President & CEO
• Overseeing LOQTORZI-driven oncology programs and pipeline development
• Guiding corporate governance and investor relations as disclosed in SEC filings

Recent Transactions

Companies — Last 90 Days

• Coherus BioSciences, Inc. (CHRS) — 1 filings, last 2026-06-03

Frequently Asked Questions

Who is Lanfear Dennis M?

Dennis M. Lanfear is the President and Chief Executive Officer of Coherus Oncology Inc, as disclosed in the SEC filing with CIK 0001420822 dated 2026-01-23. Coherus Oncology Inc is described as an oncology-focused company with LOQTORZI, a next-generation PD-1 inhibitor, and a pipeline targeting liver, lung, head & neck, and other cancers. In his role, Lanfear leads the company’…

How many SEC Form 4 filings has Lanfear Dennis M submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Lanfear Dennis M's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week